Physician profile
Tiffany Bryant
NPI 1467526723
$3,843.80
in general payments reported to CMS, 2019-2025
36 companies · $969 in 2025
The $969 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $613 · 2022: $861 · 2023: $692 · 2024: $708 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,369.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,013.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $396.08 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $301.65 | 2021-2025 | |
| Abbvie INC. | $297.27 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.17 | 2022-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $238.58 | 2022 | |
| Exact Sciences Corporation | $175.87 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $105.17 | 2022-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $92.39 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.95 | 2021-2025 | Xifaxan |
| Esperion Therapeutics, INC. | $75.33 | 2021-2025 | Nexletol |
| Seqirus USA INC | $64.89 | 2024 | Fluad, Flucelvax |
| Glaxosmithkline, LLC. | $62.74 | 2021-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $61.70 | 2021 | |
| Janssen Pharmaceuticals, INC | $50.42 | 2022-2023 | Xarelto |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.